Global Medical REIT Inc. Board Declares 2024 Fourth Quarter Common and Preferred Dividends
Global Medical REIT (NYSE: GMRE) has announced its 2024 fourth quarter dividend distributions. The company will pay a common dividend of $0.21 per share/unit on January 8, 2025, to stockholders of record as of December 20, 2024. Additionally, GMRE declared a Series A Preferred Stock dividend of $0.46875 per share, payable on January 31, 2025, to preferred stockholders of record as of January 15, 2025, covering the period from October 31, 2024, through January 30, 2025.
Global Medical REIT (NYSE: GMRE) ha annunciato i dividendi per il quarto trimestre del 2024. L'azienda pagherà un dividendo comune di 0,21 $ per azione/unità il 8 gennaio 2025, agli azionisti registrati al 20 dicembre 2024. Inoltre, GMRE ha dichiarato un dividendo per azioni privilegiate di tipo A di 0,46875 $ per azione, che sarà pagato il 31 gennaio 2025, agli azionisti privilegiati registrati al 15 gennaio 2025, coprendo il periodo dal 31 ottobre 2024 al 30 gennaio 2025.
Global Medical REIT (NYSE: GMRE) ha anunciado sus distribuciones de dividendos para el cuarto trimestre de 2024. La compañía pagará un dividendo común de 0,21 $ por acción/unidad el 8 de enero de 2025, a los accionistas registrados a partir del 20 de diciembre de 2024. Además, GMRE declaró un dividendo de acciones preferentes de la Serie A de 0,46875 $ por acción, que se pagará el 31 de enero de 2025, a los accionistas preferentes registrados a partir del 15 de enero de 2025, cubriendo el período desde el 31 de octubre de 2024 hasta el 30 de enero de 2025.
Global Medical REIT (NYSE: GMRE)는 2024년 4분기 배당금을 발표했습니다. 회사는 2025년 1월 8일에 주당 0.21 $의 일반 배당금을 2024년 12월 20일 기준 주주에게 지급할 예정입니다. 또한, GMRE는 시리즈 A 우선주 배당금 0.46875 $를 2025년 1월 31일에 지급하기로 선언하였으며, 이는 2025년 1월 15일 기준 우선주 주주에게 지급되며, 2024년 10월 31일부터 2025년 1월 30일까지의 기간을 포함합니다.
Global Medical REIT (NYSE: GMRE) a annoncé ses distributions de dividendes pour le quatrième trimestre de 2024. La société versera un dividende ordinaire de 0,21 $ par action/unité le 8 janvier 2025, aux actionnaires enregistrés au 20 décembre 2024. De plus, GMRE a déclaré un dividende d'actions privilégiées de Série A de 0,46875 $ par action, payable le 31 janvier 2025, aux actionnaires privilégiés enregistrés au 15 janvier 2025, couvrant la période du 31 octobre 2024 au 30 janvier 2025.
Global Medical REIT (NYSE: GMRE) hat seine Dividenden für das vierte Quartal 2024 bekannt gegeben. Das Unternehmen wird am 8. Januar 2025 eine gewöhnliche Dividende von 0,21 $ pro Aktie/Einheit an die Aktionäre auszahlen, die am 20. Dezember 2024 im Register eingetragen sind. Darüber hinaus erklärte GMRE eine Dividende von 0,46875 $ pro Aktie der Serie A Vorzugsaktien, die am 31. Januar 2025 an die bevorzugten Aktionäre ausgezahlt wird, die am 15. Januar 2025 im Register eingetragen sind, und die den Zeitraum vom 31. Oktober 2024 bis zum 30. Januar 2025 abdeckt.
- Consistent dividend payment maintained for both common and preferred stockholders
- Company demonstrates ability to maintain shareholder distributions
- None.
Common Dividend
The Board has declared the Company’s 2024 fourth quarter cash dividend of
Series A Preferred Dividend
The Board has also declared a quarterly cash dividend of
About Global Medical REIT Inc.
Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com.
Forward-Looking Statements
Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding our earnings, our liquidity, our tenants’ ability to pay rent to us, expected financial performance (including future cash flows associated with new tenants or the expansion of current properties), future dividends or other financial items; any other statements concerning our plans, strategies, objectives and expectations for future operations and future portfolio occupancy rates, our pipeline of acquisition opportunities and expected acquisition activity, including the timing and/or successful completion of any acquisitions and expected rent receipts on these properties, our expected disposition activity, including the timing and/or successful completion of any dispositions and the expected use of proceeds therefrom, and any statements regarding future economic conditions or performance are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241204015828/en/
Investors:
Stephen Swett
Stephen.swett@icrinc.com
(203) 682-8377
Source: Global Medical REIT Inc.
FAQ
What is Global Medical REIT's (GMRE) Q4 2024 common dividend amount?
When is GMRE's Q4 2024 common dividend record date?
What is GMRE's Series A Preferred Stock dividend for Q4 2024?